TY - JOUR
T1 - Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma
AU - Ek, Weronica E.
AU - Lagergren, Katarina
AU - Cook, Michael
AU - Wu, Anna H.
AU - Abnet, Christian C.
AU - Levine, David
AU - Chow, Wong Ho
AU - Bernstein, Leslie
AU - Risch, Harvey A.
AU - Shaheen, Nicholas J.
AU - Bird, Nigel C.
AU - Corley, Douglas A.
AU - Hardie, Laura J.
AU - Fitzgerald, Rebecca C.
AU - Gammon, Marilie D.
AU - Romero, Yvonne
AU - Liu, Geoffrey
AU - Ye, Weimin
AU - Vaughan, Thomas L.
AU - MacGregor, Stuart
AU - Whiteman, David C.
AU - Westberg, Lars
AU - Lagergren, Jesper
N1 - Publisher Copyright:
© 2015 UICC.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - The strong male predominance in Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) remains inadequately explained, but sex hormones might be involved. We hypothesized that single nucleotide polymorphisms (SNPs) in the androgen pathway influence risk of developing BE and EAC. This genetic-epidemiological analysis included 14 studies from Australia, Europe and North America. Polymorphisms in 16 genes coding for the androgen pathway were analyzed using a gene-based approach: versatile gene-based test association study. This method evaluates associations between a trait and all SNPs within a specific gene rather than each SNP marker individually as in a conventional GWAS. The data were stratified for sex, body-mass index, waist-to-hip ratio, tobacco smoking and gastroesophageal reflux status. Included were data from 1,508 EAC patients, 2,383 BE patients and 2,170 control participants. SNPs within the gene CYP17A1 were associated with risk of BE in the sexes combined (p = 0.002) and in males (p = 0.003), but not in females separately (p = 0.3). This association was found in tobacco smokers (p = 0.003) and in BE patients without reflux (p = 0.004), but not in nonsmokers (p = 0.2) or those with reflux (p = 0.036). SNPs within JMJD1C were associated with risk of EAC in females (p = 0.001). However, none of these associations replicated in a subsequent sample. Fourteen other genes studied did not reach statistically significant levels of association with BE, EAC or the combination of BE and EAC, after correcting for the number of genes included in the analysis. In conclusion, genetic variants in the androgen-related genes CYP17A1 and JMJD1C might be associated with risk of BE and EAC, respectively, but replication data with larger sample sizes are needed. What's new? Patients who develop Barrett's esophagus (BE) or esophageal adenocarcinoma (EAC) are more likely to be male. The reason for this is unknown, but it could due to the influence of sex hormones. In this genetic-epidemiologic study, the authors found that SNP variants in the androgen-related genes CYP17A1 and JMJD1C may be associated with risk of BE and EAC, respectively. These results could provide insight into the aetiology of BE and EAC and might also lead to potential therapeutic targets.
AB - The strong male predominance in Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) remains inadequately explained, but sex hormones might be involved. We hypothesized that single nucleotide polymorphisms (SNPs) in the androgen pathway influence risk of developing BE and EAC. This genetic-epidemiological analysis included 14 studies from Australia, Europe and North America. Polymorphisms in 16 genes coding for the androgen pathway were analyzed using a gene-based approach: versatile gene-based test association study. This method evaluates associations between a trait and all SNPs within a specific gene rather than each SNP marker individually as in a conventional GWAS. The data were stratified for sex, body-mass index, waist-to-hip ratio, tobacco smoking and gastroesophageal reflux status. Included were data from 1,508 EAC patients, 2,383 BE patients and 2,170 control participants. SNPs within the gene CYP17A1 were associated with risk of BE in the sexes combined (p = 0.002) and in males (p = 0.003), but not in females separately (p = 0.3). This association was found in tobacco smokers (p = 0.003) and in BE patients without reflux (p = 0.004), but not in nonsmokers (p = 0.2) or those with reflux (p = 0.036). SNPs within JMJD1C were associated with risk of EAC in females (p = 0.001). However, none of these associations replicated in a subsequent sample. Fourteen other genes studied did not reach statistically significant levels of association with BE, EAC or the combination of BE and EAC, after correcting for the number of genes included in the analysis. In conclusion, genetic variants in the androgen-related genes CYP17A1 and JMJD1C might be associated with risk of BE and EAC, respectively, but replication data with larger sample sizes are needed. What's new? Patients who develop Barrett's esophagus (BE) or esophageal adenocarcinoma (EAC) are more likely to be male. The reason for this is unknown, but it could due to the influence of sex hormones. In this genetic-epidemiologic study, the authors found that SNP variants in the androgen-related genes CYP17A1 and JMJD1C may be associated with risk of BE and EAC, respectively. These results could provide insight into the aetiology of BE and EAC and might also lead to potential therapeutic targets.
KW - Barrett esophagus
KW - esophageal neoplasms
KW - genome-wide association study
KW - gonadal steroid hormone
KW - hormones
KW - neoplasm
UR - http://www.scopus.com/inward/record.url?scp=84955454611&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955454611&partnerID=8YFLogxK
U2 - 10.1002/ijc.29863
DO - 10.1002/ijc.29863
M3 - Article
C2 - 26414697
AN - SCOPUS:84955454611
SN - 0020-7136
VL - 138
SP - 1146
EP - 1152
JO - International journal of cancer
JF - International journal of cancer
IS - 5
ER -